IRVING, Texas--(BUSINESS WIRE)--Delivering testosterone via bioabsorbable pellets inserted under the skin is a low-risk approach to long-term hormone therapy for women and men, according to ...
Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...
IRVING, Texas--(BUSINESS WIRE)--Women who took testosterone via hormone pellets as part of bioidentical hormone replacement therapy (BHRT) had a 35.5% lower incidence of invasive breast cancer ...
On Thursday, Jefferies, a global investment banking firm, initiated coverage on Biote Corp. (NASDAQ:BTMD), a hormone optimization provider, with a Buy rating and a price target of $6.55. The company, ...
The company, which generates revenue through pellet procedures, has a significant potential market of 55 million but currently has low brand awareness, with approximately 400,000 patients and around 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback